Strength: 1 g/vial,2 g/vial, 3 g/vial
Form: Injection
Reference Brands: Ifex® (US), Holoxan® (EU)
Strength: 20 mg/0.5 mL, 80 mg/2 mL, 160 mg/4 mL
Reference Brands: Taxotere (US & EU)
Strength: Capsule:140 mg, 70 mg; Tablet: 140 mg
Form: Capsules and tablets
Reference Brands: Imbruvica®(US & EU)
Strength: 5 mg/1 mL (vial)
Reference Brands: Yervoy® (EU & US)
Strength: 25mg/ml
Form: Intravenous (IV)
Reference Brands: Zaltrap® (US & EU)
Strength: 1.5 mg/1.5 mL (1.5 mg vial)
Reference Brands: Elitek® (US & EU)
Strength: 200 mg
Form: Tablet
Reference Brands: Nexavar (US & EU)
Strength: 10 mg, 20 mg, 40 mg
Reference Brands: Nolvadex (USA)
Strength: 50 mg/5 mL (10 mg/mL vial)
Form: Injection (IV)
Reference Brands: Vumon® (EU & US)
Strength: Capsules: 5 mg, 20 mg, 100 mg, 140 mg; Tablets: 250 mg
Form: Oral Tablets and Oral Capsules
Reference Brands: Temodar® (US & EU)
Strength: 100 mg, 150 mg
Reference Brands: Lynparza® (US & EU)
Strength: 2.3 mg, 3 mg, 4 mg
Form: Capsules
Reference Brands: Ninlaro® (EU & US)
Strength: 10 mg, 50 mg, 100 mg
Reference Brands: Venclexta® (EU & US)
Strength: 100 mg
Form: Oral Capsules
Reference Brands: Calquence® (EU & US)
Strength: 75 mg, 100mg, 125 mg
Form: Oral Tablets
Reference Brands: Ibrance® (US & EU)
Strength: 40 mg, 80 mg
Reference Brands: Tagrisso® (US & EU)
Strength: 200 mg, 250 mg
Reference Brands: Xalkori® (US & EU)
Strength: IV infusion: 100 mg/10 mL, 500 mg/50 mL; SQ: 1400 mg/11 mL
Form: IV Infusion; Subcutaneous
Reference Brands: Rituxan®(US), MabThera®, Truxima®(EU);Ruxience®(US)
Strength: 200 mg, 250 mg, 300 mg
Form: Oral tablets
Reference Brands: Rubraca® (EU & US)
Strength: 0.25 mg/5 mL (0.05 mg/mL)
Form: IV Injection
Reference Brands: Aloxi (US & EU)
Stay updated on pharma trends and marketplace opportunities.